Regeneron Pharmaceuticals (REGN)

Capital Expenditure

-$920.90M

TTM · Period ending: · USD

REGN logo

REGN Capital Expenditure

Latest reported-$920.90M
REGN TTM CapEx (-$2.10M → -$920.90M)
High-resolution chart · PNG

REGN capital expenditure history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regeneron Pharmaceuticals Capital Expenditure — Trailing twelve months (TTM) (USD)
Period endingCapital Expenditure (USD)
-920,900,000
-857,500,000
-898,400,000
-916,700,000
-898,900,000
-933,000,000
-823,300,000
-869,800,000
-862,200,000
-764,300,000
-780,700,000
-619,400,000
-585,900,000
-626,500,000
-590,100,000
-592,800,000
-583,500,000
-578,400,000
-551,900,000
-558,400,000
-578,400,000
-559,800,000
-614,600,000
-592,200,000
-560,700,000
-525,400,000
-429,600,000
-376,100,000
-360,600,000
-378,000,000
-383,100,000
-405,237,000
-358,690,000
-301,539,000
-272,600,000
-315,418,000
-374,321,000
-458,308,000
-511,941,000
-539,265,000
-566,808,000
-667,865,000
-677,933,000
-617,696,000
-551,366,000
-382,346,000
-333,006,000
-284,440,000
-236,362,000
-199,942,000
-156,323,000
-102,509,000
-81,066,000
-59,485,000
-49,337,000
-45,464,000
-44,114,000
-46,106,000
-57,217,000
-78,190,000
-91,395,000
-99,112,000
-99,689,000
-89,743,000
-89,971,000
-98,144,000
-97,318,000
-90,742,000
-77,739,000
-53,727,000
-34,857,000
-29,847,000
-25,211,000
-20,296,000
-18,446,000
-8,924,000
-4,849,000
-3,362,000
-2,811,000
-1,954,000
-3,053,000
-4,251,000
-4,964,000
-5,940,000
-6,538,000
-6,548,000
-6,174,000
-6,132,000
-7,204,000
-10,637,000
-29,656,000
-43,542,000
-48,474,000
-50,374,000
-34,370,000
-21,799,000
-15,248,000
-10,580,000
-8,223,000
-6,788,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.